Following his presentation at the ERS Congress, Dr. Kai-Michael Beeh (Insaf Respiratory Research Institute, Wiesbaden, Germany) caught up with us to continue the discussion around green inhalers.
Questions
1. Could you give us an overview of the environmental impact of asthma inhaler use? (0:22)
2. How do dry powder inhalers compare to metered-dose inhalers in terms of their carbon footprint? (0:54)
3. What factors should be considered when prescribing dry powder inhalers and how can we facilitate this process for patients? (1:23)
4. What would be the environmental impact if every asthma patient switched to a green inhaler? (1:59)
5. How can we further reduce the carbon footprint of asthma therapy? (2:36)
Speaker disclosure: The institutions Kai-Michael Beeh represents have received compensation for services on advisory boards or consulting from AstraZeneca, Berlin Chemie, Boehringer, Chiesi, GSK, Novartis, Pohl Boskamp, Teva and Sanofi. They have also received compensations for speaker activities in scientific meetings supported by AstraZeneca, Berlin Chemie, Boehringer, Chiesi, GSK, Novartis, Pohl Boskamp, Teva, Sanofi and compensation for design and performance of clinical trials from AstraZeneca, Boehringer, GSK, Novartis, Pearl Therapeutics, Teva and Stern.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress Congress 2020.
